OVERVIEW

Biologic Therapies VII: Precision Medicine in the Biologic Era - Cases With the Masters is organized by Cleveland Clinic Center for Continuing Education.

Release Date: June 7, 2017
Expiration Date: June 7, 2019

Target Audience
The online series is designed for rheumatologists, allergists/immunologists, dermatologists, internal medicine physicians, and associated allied health practitioners, including nurse practitioners, nurses, and physician assistants interested in or using biologic therapeutics for autoimmune and inflammatory disorders.

Accreditation
The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Description
Biologic Therapies VII: Precision Medicine in the Biologic Era online series brings together world leaders in immune-based therapies and addresses cutting-edge translational immunology and the latest data on biologic therapeutics.

This webcast will review cases involving vaccinations, infections in IMIDs patients and best practices in IMID’s populations.

Learning Objectives
• Identify appropriate hepatitis B screening prior to starting nonbiologic or biologic DMARDs in rheumatic diseases.
• Evaluate the limitations of quantiferon testing in patients on immunosuppressive therapy.

Additional details will be posted as soon as they are available.